查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1883043

連續性腎臟替代療法 (CRRT) 耗材市場規模、佔有率、成長及全球產業分析：按類型、應用和地區劃分的洞察與預測 (2024-2032)

Continuous Renal Replacement Therapy (CRRT) Consumables Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 請詢問到貨日

價格

連續性腎臟替代療法 (CRRT) 耗材市場成長驅動因子

在全球急性腎損傷 (AKI) 和慢性腎臟病負擔日益加重的背景下，全球連續性腎臟替代療法 (CRRT) 耗材市場持續成長。根據最新的行業分析，受重症監護室 (ICU) 入院人數增加和對連續性腎臟替代療法依賴性提高的推動，預計到 2024 年，市場規模將達到 8.47 億美元。到 2025 年，受 CRRT 技術進步和全球重症監護室對 CRRT 的日益普及的推動，預計市場規模將進一步擴大至 9.126 億美元。預計到 2032 年，CRRT 耗材市場規模將達到 15.815 億美元，這反映了數位化工具的日益普及、產品創新以及基於價值的腎臟護理模式的發展。

市場驅動因素

最強勁的成長因素之一是急性腎損傷 (AKI) 發生率的上升，尤其是在重症患者中。根據 2023 年 9 月《腎臟病學雜誌》的報道，全球每年將有 1,330 萬人發生 AKI，其中大多數發生在低收入和中等收入地區。 AKI 患者數量的增加直接推高了重症監護室 (ICU) 對 CRRT 治療的需求，導致濾器、透析液、置換液和抗凝血劑的消耗量增加。

產品創新也進一步推動了市場成長。 2023年3月，Quanta Dialysis Technologies的Quanta Dialysis System獲得FDA批准，該系統具備CVVHD和SCUF模式，提高了重症監護環境下治療的可及性和靈活性。

市場限制因子

儘管CRRT具有諸多益處，但由於需要專門的基礎設施、熟練的ICU醫護人員以及高昂的治療費用，其普及受到限制。 2025年《腎臟國際報告》的一項調查指出，由於缺乏專業知識和高昂的費用，CRRT服務在印度大部分地區仍然無法取得。報告指出，在印度，單次CRRT治療的費用在500至800美元之間，這使得許多發展中國家的患者難以負擔這項治療。此外，與過濾器、管路、透析液和耗材相關的持續費用也進一步加重了治療負擔，限制了其廣泛應用。

市場機會

隨著醫院向以價值為導向、以結果為驅動的腎臟護理模式轉型，對先進的CRRT耗材的需求持續增長。製造商正致力於開發新一代過濾器、輸液裝置和濾芯，以提高毒素清除效率並減少治療中斷。 2024年3月，費森尤斯醫療宣布推出一款基於擴增實境（AR）的培訓應用程序，旨在簡化重症監護室（ICU）專業人員的CRRT培訓，這標誌著腎臟護理正朝著數位化整合的方向發展。

市場挑戰

一個顯著的挑戰是缺乏標準化的治療方案，因為CRRT的設定在不同國家、醫院和醫生之間差異很大。劑量、治療選擇、抗凝血方法和液體平衡策略的差異使得企業難以設計出通用的CRRT耗材。這種缺乏標準化的情況增加了監管審批的難度，並減緩了創新耗材的普及。

主要市場趨勢

技術創新正在重塑 CRRT 領域。數位追蹤、自動化治療控制和整合感測器正成為現代 CRRT 系統的關鍵組成部分。百特公司近期推出的 PrisMax 系統將 TherMax 血液加熱技術與先進的治療設定相結合，簡化了 CRRT 管理。醫院與製造商之間的訂閱協議也正在興起，這降低了營運成本並確保了耗材的穩定供應。

區域展望

北美

北美將在 2024 年繼續保持最大市場地位，達到 3.236 億美元。這反映了 CRRT 的高普及率、先進的透析基礎設施和強大的 ICU 容量。由於急性腎損傷 (AKI) 的日益普遍以及政府支持的各項舉措（例如美國腎臟護理 2025 年腎臟病學培訓計劃），美國將繼續引領市場，加強腎臟護理團隊建設。

歐洲

在強大的臨床研究、先進的醫院基礎設施以及日益嚴重的腎臟疾病負擔的支持下，歐洲在2024年佔據了較大的市場佔有率。德國在腎臟疾病預防研究方面投資了1208萬美元，進一步推動了該地區的成長。

亞太地區

預計到2032年，亞太地區的複合年增長率將最高。人口老化和腎臟疾病發病率的上升（例如，到2023年，中國60歲及以上的老年人口將達到2.97億）顯著增加了對連續性腎臟替代療法（CRRT）的需求。醫院網路的擴張和醫療保健投資的增加進一步增強了市場前景。

拉丁美洲、中東和非洲

由於腎臟護理計畫的擴展，預計拉丁美洲將保持穩定成長。同時，中東和非洲對透析中心和重症監護室 (ICU) 升級的投資正在推動市場發展。例如，SAHA 和 PureHealth 正在合作建立阿布達比透析中心，計劃於 2025 年投入使用。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：主要發現

  • 主要國家末期腎病患病率
  • 主要公司新產品發布
  • 主要產業趨勢（併購、合作等）
  • 腎臟替代療法的技術進步治療

第五章：全球連續性腎臟替代療法 (CRRT) 耗材市場分析、洞察與預測 (2019-2032)

  • 按類型劃分的市場分析、洞察與預測
    • 透析液
    • 置換液
    • 濾鏡
    • 導管
    • 其他
  • 按模式劃分的市場分析、洞察與預測
    • 慢速連續超濾 (SCUF)
    • 連續性靜脈-靜脈血液濾過 (CVVH)
    • 連續性靜脈-靜脈血液透析 (CVVHD)
    • 連續性靜脈-靜脈血液透析濾過 (CVVHDF)
  • 按地區劃分的市場分析、洞察與預測
    • 北美美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美連續性腎臟替代療法 (CRRT) 耗材市場分析、洞察與預測 (2019-2032)

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第七章：亞太地區連續性腎臟替代療法 (CRRT) 耗材市場分析、洞察與預測 (2019-2032)

  • 依國家/地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第八章：拉丁美洲連續性腎臟替代療法 (CRRT) 耗材市場分析、洞察與預測 (2019-2032)

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第九章：中東和非洲連續性腎臟替代療法 (CRRT) 耗材市場分析、洞察與預測 (2019-2032)

  • 依國家劃分
    • 海灣合作委員會 (GCC)
    • 南非
    • 中東其他地區非洲

第十章：競爭分析

  • 全球市佔率分析（2024）
  • 公司簡介
  • 百特
  • 貝朗集團
  • 費森尤斯醫療股公司
  • 旭化成醫療株式會社（旭化成株式會社）
  • 尼普洛
  • 東麗醫療株式會社（東麗工業株式會社）
  • 日機裝株式會社
  • 美敦力
  • 其他主要參與者
Product Code: FBI113670

Growth Factors of continuous renal replacement therapy (CRRT) consumables Market

The global continuous renal replacement therapy (CRRT) consumables market continues to rise as the burden of acute kidney injury (AKI) and chronic kidney disease accelerates worldwide. According to the latest industry analysis, the market was valued at USD 847.0 million in 2024, supported by growing ICU admissions and increasing reliance on continuous renal therapies. In 2025, the market is projected to increase further to USD 912.6 million, driven by advancements in CRRT technologies and broader adoption across intensive care units globally. By 2032, the CRRT consumables market is forecasted to reach USD 1,581.5 million, reflecting the growing integration of digital tools, product innovation, and value-based renal care models.

Market Drivers

One of the strongest growth drivers is the rising incidence of acute kidney injury, especially among critically ill patients. The Journal of Nephrology reported in September 2023 that 13.3 million individuals worldwide develop AKI every year, with most cases occurring in low- and middle-income regions. The growing AKI population directly increases the demand for CRRT therapies in ICU settings, leading to higher consumption of filters, dialysates, replacement solutions, and anticoagulants.

Product innovation further fuels market growth. In March 2023, Quanta Dialysis Technologies received FDA approval for its Quanta Dialysis System featuring CVVHD and SCUF modes, improving accessibility and treatment flexibility for critical care environments.

Market Restraints

Despite its benefits, CRRT adoption is restricted by the need for specialized infrastructure, skilled ICU staff, and high treatment costs. A 2025 Kidney International Reports study highlighted that CRRT services remain unavailable in most parts of India due to limited expertise and high costs. The same report noted that each CRRT session in India costs USD 500-800, making the therapy inaccessible for many patients in developing regions. The recurring expenses associated with filters, tubing sets, dialysates, and consumables further add to the financial burden, limiting widespread use.

Market Opportunities

As hospitals shift toward value-based, outcome-oriented renal care, demand for advanced CRRT consumables continues to expand. Manufacturers are increasingly focusing on creating next-generation filters, fluid sets, and cartridges designed to improve toxin removal efficiency and reduce therapy interruptions. In March 2024, Fresenius Medical Care launched an augmented-reality-based training app to simplify CRRT education for ICU professionals, representing a move toward digitally integrated renal care.

Market Challenges

A notable challenge is the lack of standardized treatment protocols, as CRRT settings differ significantly by country, hospital, and physician. Variations in dosing, modality choice, anticoagulation methods, and fluid balance strategies make it difficult for companies to design universally compatible CRRT consumables. This lack of standardization also complicates regulatory approvals and slows adoption of innovative consumable products.

Key Market Trends

Technological innovation is reshaping the CRRT landscape. Digital tracking features, automated therapy controls, and integrated sensors are becoming vital components of modern CRRT systems. Baxter's PrisMax system, launched earlier, integrates TherMax blood warming technology and advanced therapy settings to simplify CRRT management. Subscription-based agreements between hospitals and manufacturers are also emerging, reducing operational costs and ensuring steady supply of consumables.

Regional Outlook

North America

North America remained the largest market in 2024, valued at USD 323.6 million, reflecting high CRRT adoption, advanced dialysis infrastructure, and strong ICU capacity. The U.S. continues to lead due to increased AKI prevalence and government support initiatives such as U.S. Renal Care's 2025 nephrology training program to strengthen the renal workforce.

Europe

Europe held a significant share in 2024, supported by strong clinical research, advanced hospital infrastructure, and rising renal disease burden. Germany's USD 12.08 million investment in kidney disease prevention research further enhances regional growth.

Asia Pacific

Asia Pacific is expected to record the highest CAGR through 2032. Aging populations and rising kidney disease incidence-such as China's 297 million population aged 60+ in 2023-significantly increase CRRT demand. Expanding hospital networks and increasing healthcare investment further strengthen market prospects.

Latin America & Middle East/Africa

Latin America shows steady growth due to expanding renal care programs, while the Middle East & Africa benefit from investments in dialysis centers and ICU upgrades, such as the 2025 partnership between SAHA and PureHealth to establish a dialysis center in Abu Dhabi.

Conclusion

With market size increasing from USD 847.0 million in 2024 to USD 1,581.5 million by 2032, the CRRT consumables market is on a strong growth trajectory. Rising AKI prevalence, growing ICU capacity, product innovation, and digital integration will continue to shape market expansion. Key players such as Baxter, Fresenius Medical Care, Medtronic, and Asahi Kasei are expected to drive future advancements through strategic partnerships and technology-driven product development.

Segmentation

By Type

  • Dialysates
  • Replacement Solutions
  • Filters
  • Catheters
  • Others

By Modality

  • Slow Continuous Ultra Filtration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)

By Geography

  • North America (By Type, Modality, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Modality, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Type, Modality, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Type, Modality, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Modality, and Country/Sub-region)
    • GCC
    • South Africa
    • Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of End Stage Renal Disease, Key Countries
  • 4.2. New Product Launches, By Key Players
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
  • 4.4. Technological Advancements in Renal Replacement Therapy

5. Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Dialysates
    • 5.1.2. Replacement Solutions
    • 5.1.3. Filters
    • 5.1.4. Catheters
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Modality
    • 5.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 5.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 5.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 5.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Dialysates
    • 6.1.2. Replacement Solutions
    • 6.1.3. Filters
    • 6.1.4. Catheters
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Modality
    • 6.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 6.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 6.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 6.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 6.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 6.3.1. U.K.
    • 6.3.2. Germany
    • 6.3.3. France
    • 6.3.4. Spain
    • 6.3.5. Italy
    • 6.3.6. Scandinavia
    • 6.3.7. Rest of Europe

7. Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Dialysates
    • 7.1.2. Replacement Solutions
    • 7.1.3. Filters
    • 7.1.4. Catheters
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Modality
    • 7.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 7.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 7.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 7.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. Japan
    • 7.3.2. China
    • 7.3.3. India
    • 7.3.4. Australia
    • 7.3.5. Southeast Asia
    • 7.3.6. Rest of Asia Pacific

8. Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Dialysates
    • 8.1.2. Replacement Solutions
    • 8.1.3. Filters
    • 8.1.4. Catheters
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Modality
    • 8.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 8.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 8.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 8.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Brazil
    • 8.3.2. Mexico
    • 8.3.3. Rest of Latin America

9. Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Dialysates
    • 9.1.2. Replacement Solutions
    • 9.1.3. Filters
    • 9.1.4. Catheters
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Modality
    • 9.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 9.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 9.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 9.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. GCC
    • 9.3.2. South Africa
    • 9.3.3. Rest of Middle East & Africa

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2024)
  • 10.2. Company Profiles
    • 10.2.1. Baxter
      • 10.2.1.1. Overview
      • 10.2.1.2. Products
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. B Braun SE
      • 10.2.2.1. Overview
      • 10.2.2.2. Products
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. Fresenius Medical Care AG & Co. KGaA
      • 10.2.3.1. Overview
      • 10.2.3.2. Products
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation)
      • 10.2.4.1. Overview
      • 10.2.4.2. Products
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. NIPRO
      • 10.2.5.1. Overview
      • 10.2.5.2. Products
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)
    • 10.2.6. TORAY MEDICAL CO, LTD. (TORAY INDUSTRIES, INC.)
      • 10.2.6.1. Overview
      • 10.2.6.2. Products
      • 10.2.6.3. SWOT Analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. Financials (Based on Availability)
    • 10.2.7. Nikkiso Co., Ltd.
      • 10.2.7.1. Overview
      • 10.2.7.2. Products
      • 10.2.7.3. SWOT Analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. Financials (Based on Availability)
    • 10.2.8. Medtronic
      • 10.2.8.1. Overview
      • 10.2.8.2. Products
      • 10.2.8.3. SWOT Analysis
      • 10.2.8.4. Recent Developments
      • 10.2.8.5. Strategies
      • 10.2.8.6. Financials (Based on Availability)
    • 10.2.9. Other Prominent Players

List of Tables

  • Table 1: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 2: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2019-2032
  • Table 3: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 4: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 5: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2019-2032
  • Table 6: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 7: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 8: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2019-2032
  • Table 9: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 10: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 11: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2019-2032
  • Table 12: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 13: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 14: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2019-2032
  • Table 15: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 16: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 17: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2019-2032
  • Table 18: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2024 & 2032
  • Figure 3: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2024 & 2032
  • Figure 4: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Region, 2024 & 2032
  • Figure 5: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2024 & 2032
  • Figure 6: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2024
  • Figure 7: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2024 & 2032
  • Figure 8: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2024
  • Figure 9: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country, 2024 & 2032
  • Figure 10: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country, 2024
  • Figure 11: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2024 & 2032
  • Figure 12: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2024
  • Figure 13: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2024 & 2032
  • Figure 14: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2024
  • Figure 15: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 16: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 17: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2024 & 2032
  • Figure 18: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2024
  • Figure 19: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2024 & 2032
  • Figure 20: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2024
  • Figure 21: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 22: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 23: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2024 & 2032
  • Figure 24: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2024
  • Figure 25: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2024 & 2032
  • Figure 26: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2024
  • Figure 27: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 28: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 29: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2024 & 2032
  • Figure 30: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2024
  • Figure 31: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2024 & 2032
  • Figure 32: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2024
  • Figure 33: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 34: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 35: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Share (%), By Company, 2024